TIDMVEC

RNS Number : 8894P

Vectura Group plc

31 May 2018

VECTURA GROUP PLC (the "Company")

Chippenham, UK - 31 May 2018: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading inhaled product formulation, device design and development business, announces that Frank Condella, Non-Executive Director, joined the Board of Mayne Pharma Group Limited, an ASX-listed specialty pharmaceutical company with effect from 30 May 2018.

This information is disclosed to the London Stock Exchange in accordance with the requirements under paragraph 9.6.14R of the United Kingdom Listing Rules relating to the disclosure of changes to the roles, functions and responsibilities of directors.

- Ends -

Enquiries

 
Vectura Group plc                                   +44 (0)20 7881 0524 
 
John Murphy 
 Company Secretary 
 
 
Consilium Strategic Communications                  +44 (0)20 3709 5700 
 
Mary-Jane Elliott / Susan Stuart/ Jessica Hodgson

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNFMGFKFMZGRZM

(END) Dow Jones Newswires

May 31, 2018 09:35 ET (13:35 GMT)

Vectura (LSE:VEC)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Vectura Charts.
Vectura (LSE:VEC)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Vectura Charts.